3[1]Bystryn JC. Immune mechanisms in vitiligo[J]. Clin Dermatol,1997,15(6):853-861.
4[2]Kim DG, Kim HY, Kim MY, Lincomycin abrogates dexamethasone-enhanced melanogenesis in B16 melanoma cells[J]. Pigment Cell Res, 1998, 11(3):143-150.
5[3]Goldstein E, Haberman HF, Menon IA, et al. Non-psoralen treatment of vitiligo. Part Ⅱ. Less commonly used and experimental therapies[J]. Int J Derrnatol, 1992, 31(5):314-319.
7Hsiang YH, Hertzberg R, Hecht S,et al.Camptothecin induces ptotein-linked DNA breaks via mammalian DNA topoisomerase[J],J Biol Chem , 260 ( 27 ) : 14873 - 14878.
8Perez-Soler R,Fossella FV,Glisson BS,et al.Phase Ⅱ study of topoecan in patients with advanced non small cell lung cancer previously untreated with chemotherapy[J].J Clin Oncol,1996,14(2):503-513.
9Wang F, Cao Y, Liu H t , el al. Anti - invasion and anti - angiogenesis effect of taxol and camptothecin on melanoma cellsLJJ. Asian Nat Prod Res, 2003, 5(2):121 -129.
5Rezqaei N, Gavalas NG, Weetman AP, et al. Autoimmunity as an ae- tiological factor in vitiligo [J]. J Eur Acad Dermatol Venereol, 2007, 21(7) : 865-876.
6Ermis O, Alpsoy E, Cetin L, et al. Is the efficacy of psoralen plus a ultraviolet A therapy for vitiligo enhanced by concurrent topical calci- potriol [J]. Br J Dematol, 2001,145(3) : 472-475.
